MedTrace Logo

Obi Medical Robot: Evaluating Effectiveness Related to Usability

NCT07151950 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-09-03

No results posted yet for this study

Summary

This mixed-methods usability study evaluates the effectiveness of the Obi Gen 3 robotic feeding device in meeting user needs among providers, caregivers, and patients. Participants will complete a one-week trial using Obi in home, school, or community settings, followed by feedback surveys and optional interviews. The study seeks to validate that the device design meets usability requirements prior to broader deployment.

Conditions

  • Upper Extremity Impairments
  • Cerebral Palsy (CP)
  • ALS - Amyotrophic Lateral Sclerosis
  • Rett Syndrome

Interventions

DEVICE

One-week trial of Obi Medical device, which provides robotic assistance with feeding to persons with upper extremity impairments who are unable to self-feed in the traditional manner using utensils

This study explores the stakeholders' experiences in recommending and using Obi. Stakeholders/Participants include: 1. Persons with disabilities or conditions which prevent them from successfully using their upper extremities (UE) to self-feed independently 2. Caregivers of the persons with disabilities described above 3. Providers (OT, SLP, PT, ATP, etc.) who provide services to persons with disabilities

Sponsors & Collaborators

  • The Driving Doctor: Adaptive Driving & Rehabilitation Solutions, PC

    collaborator OTHER

  • Desin LLC

    lead INDUSTRY

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-10
Primary Completion
2025-08-12
Completion
2025-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07151950 on ClinicalTrials.gov